Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|June 1, 1999
Supplements and Featured Publications
- Clinical and Economic Impact of Breast Cancer Treatment and Prevention in High-Risk Women
- Volume 5
- Issue 6 Suppl
Overview of Cancer Economics
Author(s)C. Daniel Mullins, PhD
Advertisement
Articles in this issue
about 27 years ago
Participating Facultyabout 27 years ago
Medical and Economic Impact of Breast Cancer Treatment and Preventionabout 27 years ago
Benefits Foregone: Too Much of the Wrong and Too Little of the Rightabout 27 years ago
Breast Cancer Epidemiology: An Overviewabout 27 years ago
Breast Cancer Stage Cost Analysis in a Managed Care Populationabout 27 years ago
The Cost Effectiveness of Tamoxifen in the Prevention of Breast Cancerabout 27 years ago
Question-and-Answer Sessionabout 27 years ago
Selected AbstractsAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
2
5 Things to Know About the FDA's Peptide Reversal
3
FDA Approves First Orexin Agonist for Narcolepsy Type 1
4
Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South
5